Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Recent Registrations
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
January
-
February
-
March
-
April
-
May
-
June
- July -
August
-
September
-
Oktober
-
November
-
December
|
2002
-
2003
-
2004
-
2005
-
2006
-
2007
-
2008
-
2009
-
2010
-
2011
-
2012
-
2013
-
2014
-
2015
- 2016 -
2017
-
2018
-
2019
-
2020
-
2021
-
2022
-
2023
-
2024
-
2025
July 2016 - 57 products
IP
CI
Duokopt
5 ml
12.96
30.50
10 %
Eye drops: 2 Active Agents
THEA Pharma S.A.
●
B / SL / SG
FB
G
IP
CI
Duokopt
3 x 5 ml
37.95
57.60
10 %
Eye drops: 2 Active Agents
THEA Pharma S.A.
●
B / SL / SG
FB
G
IP
CI
Glatiramyl 20 mg/ml
28
654.31
728.00
10 %
Injection solution in prefilled syringe: Glatirameri Acetas 20 mg/ml
Viatris Pharma GmbH
B / SL / SG
FB
G
IP
Methotrexat-Mepha
rheuma/derm 7.5 mg/0.30 ml
13.04
30.60
10 %
Injection solution in prefilled syringe: Methotrexatum 7.5mg / 0.3ml
Injection solution in prefilled syringe: Methotrexatum 7.5mg / 0.3ml
Mepha Pharma AG
A / SL / SG
FB
G
IP
Methotrexat-Mepha
rheuma/derm 10 mg/0.4 ml
14.73
32.45
10 %
Injection solution in prefilled syringe: Methotrexatum 10mg / 0.4ml
Injection solution in prefilled syringe: Methotrexatum 10mg / 0.4ml
Mepha Pharma AG
A / SL / SG
FB
G
IP
Methotrexat-Mepha
rheuma/derm 12.5
mg/0.3125 ml
15.87
33.65
10 %
Injection solution in prefilled syringe: Methotrexatum 12.5mg / 0.3125ml
Injection solution in prefilled syringe: Methotrexatum 12.5mg / 0.3125ml
Mepha Pharma AG
A / SL / SG
FB
G
IP
Methotrexat-Mepha
rheuma/derm 15 mg/0.375 ml
16.99
34.90
10 %
Injection solution in prefilled syringe: Methotrexatum 15mg / 0.375ml
Injection solution in prefilled syringe: Methotrexatum 15mg / 0.375ml
Mepha Pharma AG
A / SL / SG
FB
G
IP
Methotrexat-Mepha
rheuma/derm 17.5
mg/0.4375 ml
18.01
36.00
10 %
Injection solution in prefilled syringe: Methotrexatum 17.5mg / 0.4375ml
Injection solution in prefilled syringe: Methotrexatum 17.5mg / 0.4375ml
Mepha Pharma AG
A / SL / SG
FB
G
IP
Methotrexat-Mepha
rheuma/derm 20 mg/0.5 ml
19.03
37.10
10 %
Injection solution in prefilled syringe: Methotrexatum 20mg / 0.5ml
Injection solution in prefilled syringe: Methotrexatum 20mg / 0.5ml
Mepha Pharma AG
A / SL / SG
FB
G
IP
Methotrexat-Mepha
rheuma/derm 25 mg/0.625 ml
21.45
39.75
10 %
Injection solution in prefilled syringe: Methotrexatum 25mg / 0.625ml
Injection solution in prefilled syringe: Methotrexatum 25mg / 0.625ml
Mepha Pharma AG
A / SL / SG
FB
G
L
IP
CI
Pramipexol ER Zentiva
0.375 mg
10
4.53
14.15
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Zentiva
0.75 mg
10
8.38
25.55
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Zentiva
0.75 mg
30
23.39
41.85
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Zentiva 1.5 mg
30
46.78
67.30
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 1.5 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Zentiva 3.0 mg
30
93.56
118.15
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 3 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Pramipexol ER Zentiva 4.5 mg
30
140.34
169.05
10 %
Delayed release tablets: Pramipexoli Dihydrochloridum Monohydricum 4.5 mg
Helvepharm AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 50 mg
60
30.51
49.60
10 %
Delayed release tablets: Quetiapinum 50 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 150 mg
60
58.38
79.90
10 %
Delayed release tablets: Quetiapinum 150 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 150 mg
100
97.30
122.25
10 %
Delayed release tablets: Quetiapinum 150 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 200 mg
60
72.22
94.95
10 %
Delayed release tablets: Quetiapinum 200 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 200 mg
100
118.57
145.35
10 %
Delayed release tablets: Quetiapinum 200 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 300 mg
60
102.06
127.40
10 %
Delayed release tablets: Quetiapinum 300 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 300 mg
100
167.35
198.40
10 %
Delayed release tablets: Quetiapinum 300 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 400 mg
60
141.66
170.50
10 %
Delayed release tablets: Quetiapinum 400 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Quetiapin XR Spirig HC 400 mg
100
236.10
273.20
10 %
Delayed release tablets: Quetiapinum 400 mg
Spirig HealthCare AG
B / SL / SG
FB
G
IP
CI
Anastrozol Devatis 1 mg
30
55.42
76.65
10 %
Coated tablets: Anastrozolum 1 mg
Devatis AG
B / SL / SG
FB
G
IP
CI
Anastrozol Devatis 1 mg
100
182.48
214.80
10 %
Coated tablets: Anastrozolum 1 mg
Devatis AG
B / SL / SG
FB
G
L
IP
CI
Eplerenon Spirig HC 25mg
30
28.35
47.15
10 %
Coated tablets: Eplerenonum 25 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
CI
Eplerenon Spirig HC 25mg
100
94.64
118.95
10 %
Coated tablets: Eplerenonum 25 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
CI
Eplerenon Spirig HC 50mg
30
28.35
47.15
10 %
Coated tablets: Eplerenonum 50 mg
Spirig HealthCare AG
B / SL / SG
FB
G
L
IP
CI
Eplerenon Spirig HC 50mg
100
94.64
118.95
10 %
Coated tablets: Eplerenonum 50 mg
Spirig HealthCare AG
●
B / SL / SG
FB
G
L
IP
CI
Eplerenon-Mepha 25 mg
30
28.36
47.15
10 %
Coated tablets: Eplerenonum 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Eplerenon-Mepha 25 mg
100
94.64
118.95
10 %
Coated tablets: Eplerenonum 25 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Eplerenon-Mepha 50 mg
30
28.36
47.15
10 %
Coated tablets: Eplerenonum 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
L
IP
CI
Eplerenon-Mepha 50 mg
100
94.64
118.95
10 %
Coated tablets: Eplerenonum 50 mg
Mepha Pharma AG
B / SL / SG
FB
G
IP
CI
Letrozol Devatis 2.5 mg
30
47.00
67.95
10 %
Coated tablets: Letrozolum 2.5 mg
Devatis AG
B / SL / SG
FB
G
IP
CI
Letrozol Devatis 2.5 mg
100
155.92
187.30
10 %
Coated tablets: Letrozolum 2.5 mg
Devatis AG
B / SL / SG
FB
G
IP
CI
Rasagilin Sandoz 1 mg
30
57.60
79.05
10 %
Tablets: Rasagilinum 1 mg
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
IP
CI
Rasagilin Sandoz 1 mg
100
163.93
194.70
10 %
Tablets: Rasagilinum 1 mg
Sandoz
Pharmaceuticals AG
●
B / SL / SG
FB
G
L
IP
CI
Imlygic 10e6
1 ml
2038.89
2233.85
10 %
Injection solution: Talimogenum Laherparepvecum 1
Amgen Switzerland AG
A / SL
FB
G
L
IP
CI
Imlygic 10e8
Durchstechflasche(n) à 1 ml
2038.89
2233.85
10 %
Injection solution: Talimogenum Laherparepvecum 100
Amgen Switzerland AG
A / SL
FB
G
L
IP
CI
Synagis 50 mg/0.5 ml
558.68
624.00
10 %
Injection solution: Palivizumabum 50mg / 0.5ml
AstraZeneca AG
A / SL
FB
G
L
IP
CI
Synagis 100 mg/1 ml
927.62
1025.25
10 %
Injection solution: Palivizumabum 100 mg/ml
AstraZeneca AG
A / SL
FB
G
L
IP
CI
PP
Tagrisso 40 mg
30
5012.50
5450.65
10 %
Coated tablets: Osimertinibum 40 mg
AstraZeneca AG
A / SL
FB
G
L
IP
CI
PP
Tagrisso 80 mg
30
5012.50
5450.65
10 %
Coated tablets: Osimertinibum 80 mg
AstraZeneca AG
A / SL
FB
G
L
IP
CI
Vi-De 3 dose par mois
5 ml
1.42
2.60
10 %
Solution (oral): Cholecalciferolum 600µg / 5ml
VERFORA SA
D / SL
FB
G
L
IP
CI
Vi-De 3 dose par mois
3 x 5 ml
4.26
13.85
10 %
Solution (oral): Cholecalciferolum 600µg / 5ml
VERFORA SA
B / SL
FB
G
L
IP
CI
Vi-De 3 dose par mois
6 x 5 ml
8.52
25.70
10 %
Solution (oral): Cholecalciferolum 600µg / 5ml
VERFORA SA
B / SL
FB
G
IP
CI
Drossadin Spray 0.2%
50 ml
10.68
19.70
10 %
Spray zur Anwendung in der Mundhöhle: Hexetidinum 2 mg/ml/ml
Drossapharm AG
D / SL
FB
G
IP
CI
Duokopt
10 ml
PR
PR
k.A.
Eye drops: 2 Active Agents
THEA Pharma S.A.
B
FB
G
IP
CI
Duokopt
2 x 10 ml
PR
PR
k.A.
Eye drops: 2 Active Agents
THEA Pharma S.A.
B
FB
G
Ph
Fisherman’s Friend
Spearmint Halspastillen
25 g
PR
PR
k.A.
Lozenges: Levomentholum 4.83 mg
Ricola AG
E
FB
G
Ph
Fisherman’s Friend
Spearmint Halspastillen
2 x 25 g
PR
PR
k.A.
Lozenges: Levomentholum 4.83 mg
Ricola AG
E
FB
G
IP
CI
Kanuma 2 mg/ml
PR
PR
k.A.
Concentrate for infusion: Sebelipasum Alfa 2 mg/ml
Alexion Pharma GmbH
B
FB
G
IP
PP
Praxbind 2.5 g
2 x 50 ml
PR
PR
k.A.
Injektions- bzw. Infusionslösung: Idarucizumabum 2500mg / 50ml
Boehringer Ingelheim
(Schweiz) GmbH
A
FB
G
IP
V/S
PP
Gardasil 9
PR
PR
k.A.
Injektionssuspension in Fertigspritze: 9 Active Agents
MSD Merck Sharp &
Dohme AG
B
FB
G
IP
V/S
PP
Gardasil 9
10
PR
PR
k.A.
Injektionssuspension in Fertigspritze: 9 Active Agents
MSD Merck Sharp &
Dohme AG
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
